Jayme Brooks
Analyst · EF Hutton. Please proceed
Thanks, Mike. Our press release and Form 10-K, which was filed yesterday, will provide extensive detail on our financials. So I'll focus on some key highlights. Overall, our ODR transition continues to track well with the ODR segment up to 43.6% of the consolidated revenue for the full year. And more importantly, the ODR segment accounted for 58.8% of the consolidated gross profit for the year. We closed the year with a solid fourth quarter. Most notably, adjusted EBITDA for the quarter was $11.6 million, resulting in adjusted EBITDA for the full year of $31.8 million, which exceeded the high end of our guidance. Our free cash flow conversion as a percentage of adjusted EBITDA was approximately 78% for the quarter and 74% for the full year. Focusing on the income statement, our gross margin continued to trend positively. Consolidated gross margin during the fourth quarter was up to 20.4%, resulting in full year gross margin of 18.9%. This success continued to be underpinned by our strategic focus on our higher-margin ODR segment, which accounted for 44.6% of the fourth quarter consolidated revenue compared with 30.8% in the year ago quarter. As I mentioned earlier, for the full year, ODR accounted for 43.6% of consolidated revenue. That's up from 28.6% in 2021. SG&A expense in the fourth quarter was $21.8 million, up $3 million from the year ago period. Full year SG&A expense was $77.9 million, up $6.4 million from the prior year. Digging into the significant driver of the net increase in our SG&A, the majority of the $6.4 million increase from 2021 to 2022 was the full year effect of SG&A expense from the Jake Marshall entities, which is approximately $5.9 million. We have also made strategic investments in 2022, which are reflected in the SG&A of the ODR segment, consisting of mostly salespeople and supported staff. Given that segment's general profile of quicker hitting small dollar value work than historically has been the case with GCR, it requires more selling and transactional support to grow the relationships, drive revenue and those margins and those investments were also a factor in the increased SG&A for the full year. When looking to model 2023 SG&A, the full year should run at a similar rate as a percentage of revenue to 2022. Consistent with our prior year, our revenue in the second half of the year is expected to be stronger than in the first half which will cause SG&A expense to be a higher percentage of revenue in the first half of the year. In addition, the first half of the year will include non-recurring CEO succession costs associated with the transition that was announced in January. These costs are expected to be over $1 million with the majority of the costs hitting in Q1. These costs will run through SG&A and will be an adjustment to our EBITDA calculation and will impact net income and earnings. Additionally, during 2022, the restructuring that took place to wind-down our SoCal operation in our GCR segment in Eastern Pennsylvania negatively impacted our income and earnings before income taxes by approximately $6 million. The majority of those costs and distractions are behind us. However, there have been some delays in wrapping up certain projects and claims, and we will see some continuation of costs into 2023. Once those are completed, we expect to see a positive impact on the business and, in particular, our gross margins. The fair value of contingency consideration for Jake Marshall acquisition also negatively impacted net income and earnings in 2022. However, the fact that the first earn-out target was met as of December 31, 2022, is very positive as it was well earned by the Jake Marshall team as they exceeded their planned EBITDA for the year. For 2023, we expect minimal expense related to the earnout as the majority of the earnout for 2023 is already accrued on the balance sheet. Turning to cash flow, as we have discussed before as a general rule of thumb, we expect our free cash flow conversion to, continue to be approximately 70% of our adjusted EBITDA when viewed on an annual or trailing 12-month period. Just given the nature of our business, cash flows can be volatile over short periods. So we really urge everyone to focus on 12-month period or longer when evaluating our cash flow performance. Our ODR shift is having the intended effect on our operating cash flow performance. Fourth quarter operating cash flow was $12.4 million and full year operating cash flow was $35.4 million. The primary use of cash we generate continues to be the reduction of debt. We paid down $13.4 million of our term debt during 2022. At December 31, total debt outstanding was $31.8 million and total cash was $36 million, allowing us to finish the year with the net debt balance of zero. We also used $2 million during Q4 on our share repurchase program, repurchasing approximately 180,000 shares of our common stock. As Charlie mentioned, we also settled one of our outstanding claims in Q4 equal to the carrying value of the claim that was in the contract asset account on the balance sheet as of September 30. Therefore, there was no impact to the income statement and the customer was billed for the amount in Q4, which is now included in accounts receivable as of December 31. We expect to receive the cash payment of approximately $10 million for this receivable in the first half of the year. This is two claims outstanding with a total gross value north of $30 million. And I'll remind everyone that the outcome of those settlement negotiations is something we cannot forecast, including the terms of the settlement amount, the timing of when the cash will actually be collected. Our balance sheet is strong. And with the business expected to continue to yield free cash flow, we currently expect to have the strategic flexibility to pursue our acquisition program without needing to turn to equity financing. And as part of our capital allocation strategy, we continue to evaluate and discuss additional share repurchase programs with our Board of Directors. I'll now hand it back to Mike.